• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2020 Fiscal Year Final Research Report

Research on pathogenesis and development of therapies for cardiac failure using dystrophin-deficient-cardiomyocytes derived from DMD patients

Research Project

  • PDF
Project/Area Number 18K07064
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49030:Experimental pathology-related
Research InstitutionShinshu University

Principal Investigator

Miyazaki Daigo  信州大学, 医学部附属病院, 講師(特定雇用) (80596370)

Co-Investigator(Kenkyū-buntansha) 中村 昭則  信州大学, 医学部, 特任教授 (10303471)
柴 直子  信州大学, 医学部, 助教 (00639289)
柴 祐司  信州大学, 学術研究院医学系, 教授 (70613503)
Project Period (FY) 2018-04-01 – 2021-03-31
KeywordsDuchenne型筋ジストロフィー / 心不全 / IGF2
Outline of Final Research Achievements

Heart failure is now becoming the most frequent cause of death in Duchenne muscular dystrophy (DMD); however, the pathomechanisms of cardiomyopathy remain unclear. We generated cardiomyocytes from DMD-specific induced pluripotent stem cells (DMD-iPSC-CMs) donated from a DMD patient, and microarray analysis revealed several proliferation-, regeneration- related genes were down-regulated in DMD-iPSC-CMs. In these genes, IGF2 and TMSB4X gene expressions were recovered along with dystrophin restoration by exon skipping in DMD-iPSC-CMs. Next, we treated iPSC-CMs from healthy person with IGF2 and TMSB4X specific siRNAs. IGF2 knock-down tend to lead decreased size of cardiomyocytes, and led to significant down-regulation of IGF1 in these iPSC-CMs. IGF1 and IGF2 bind IGF1R and activate Erk signal transduction, and are thought to maintain the size of cardiomyocyte and myocardial wall thickness. IGF2 down-regulation might deteriorate the pathology of dilated cardiomyopathy in DMD.

Free Research Field

筋疾患

Academic Significance and Societal Importance of the Research Achievements

心不全はDMDの主な死亡原因となる重要な障害であるが,心不全に関する研究は心筋の採取が難しく十分に進んでいない.DMD患者由来の心筋細胞の作成と網羅的遺伝子解析の結果, さらに健常者由来の心筋細胞に対するsiRNAによる遺伝子発現抑制実験の結果から,DMD患者由来の心筋細胞におけるIGF2発現の低下は、DMD患者の拡張型心筋症の病態を悪化させる可能性が示唆され,学術的意義のみならず心不全治療開発の基礎として社会的意義のある成果と考える.

URL: 

Published: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi